Cargando…
Transforming Growth Factor-β Suppresses the Activation of CD8(+) T-Cells When Naïve but Promotes Their Survival and Function Once Antigen Experienced : A Two-Faced Impact on Autoimmunity
OBJECTIVE—Transforming growth factor-β (TGF-β) can exhibit strong immune suppression but has also been shown to promote T-cell growth. We investigated the differential effect of this cytokine on CD8(+) T-cells in autoimmunity and antiviral immunity. RESEARCH DESIGN AND METHODS—We used mouse models f...
Autores principales: | Filippi, Christophe M., Juedes, Amy E., Oldham, Janine E., Ling, Ellie, Togher, Lisa, Peng, Yufeng, Flavell, Richard A., von Herrath, Matthias G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2551678/ https://www.ncbi.nlm.nih.gov/pubmed/18689691 http://dx.doi.org/10.2337/db08-0609 |
Ejemplares similares
-
Increased Memory Conversion of Naïve CD8 T Cells Activated during Late Phases of Acute Virus Infection Due to Decreased Cumulative Antigen Exposure
por: Fousteri, Georgia, et al.
Publicado: (2011) -
T-bet Controls Autoaggressive CD8 Lymphocyte Responses in Type 1 Diabetes
por: Juedes, Amy E., et al.
Publicado: (2004) -
Preexisting Autoantibodies Predict Efficacy of Oral Insulin to Cure Autoimmune Diabetes in Combination With Anti-CD3
por: Mamchak, Alusha A., et al.
Publicado: (2012) -
A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice
por: Gill, Ronald G., et al.
Publicado: (2016) -
Short- and Long-term Outcomes of De Novo Liver Transplant Patients Treated With Once-Daily Prolonged-Release Tacrolimus
por: Okumura, Yuichiro, et al.
Publicado: (2017)